This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.
Phillips-Medisize, a Molex company, will be exhibiting at K39 in Hall 8A at COMPAMED 2018, held November 12-15 in Düsseldorf. COMPAMED takes place in conjunction with the MEDICA 2018 World Forum for Medicine.
The Phillips-Medisize booth will showcase the company’s comprehensive end-to-end solutions for medical OEMs, including its innovative third generation Connected Health Platform (CHP). Incorporating more than a decade of experience in developing connected health solutions, the Phillips-Medisize cloud-based CHP provides a scalable medical device data system (MDDS) for pharmaceutical companies and drug delivery device developers.
Phillips-Medisize has integrated its extensive device development and manufacturing capabilities with Molex’s global expertise in electronic, electrical and fiber optic systems and solutions to provide a one-stop source for device strategy, design, and development and manufacturing services. At COMPAMED, Phillips-Medisize will feature connected health monitoring equipment solutions, therapeutic combination product drug delivery devices, and complete (disposable or reusable) diagnostic devices, subassemblies and kits.
“Phillips-Medisize is committed to building sensible, cost-effective technology that meets industry, provider and patient needs,” said Bill Welch, Chief Technology Officer, Phillips-Medisize. “As end-to-end connectivity becomes increasingly essential for patient-centered healthcare solutions, we will continue to leverage our deep knowledge, experience and partnerships. Our goal is to deliver innovative solutions from concept to commercialization that optimize outcomes as well as the patient and caregiver experience.”